Table 1.
Cocaine vaccine experimental groups.
| Group | Antigen | Prime (Day 0) (adjuvant, route) | Boost (Days 14, 28) (adjuvant, route) |
|---|---|---|---|
| 1 | None | None | None |
| 2 | KLH-cocaine | Alum, i.p. | Alum, i.p. |
| 3 | KLH-GNC | Alum, i.p. | Alum, i.p. |
| 4 | KLH-cocaine | No adjuvant, nasal | No adjuvant, nasal |
| 5 | KLH-GNC | No adjuvant, nasal | No adjuvant, nasal |
| 6 | KLH-cocaine | M7-NH2 (20 µg), nasal | M7-NH2 (20 µg), nasal |
| 7 | KLH-GNC | M7-NH2 (20 µg), nasal | M7-NH2 (20 µg), nasal |
| 8 | KLH-cocaine | Alum, s.c. | M7-NH2 (20 µg), nasal |
| 9 | KLH-GNC | Alum, s.c. | M7-NH2 (20 µg), nasal |